Athanase Innovation AB (publ) Sustainability Profile
Athanase Innovation AB (publ), headquartered in Sweden, is a pioneering force in the biotechnology sector, specialising in innovative solutions for the pharmaceutical and healthcare industries. Founded in 2018, the company has rapidly established itself as a leader in developing advanced therapeutic products, focusing on enhancing patient outcomes through cutting-edge research and technology. With a commitment to quality and innovation, Athanase Innovation offers a unique portfolio of services, including drug development and clinical trial management. The company’s emphasis on scientific excellence and strategic partnerships has positioned it favourably within the competitive landscape, earning recognition for its contributions to the field. As it continues to expand its operational reach, Athanase Innovation remains dedicated to driving advancements that address critical healthcare challenges.
DitchCarbon Score
How does Athanase Innovation AB (publ)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Athanase Innovation AB (publ)'s score of 26 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Athanase Innovation AB (publ)'s reported carbon emissions
Athanase Innovation AB (publ), headquartered in Sweden, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that Athanase Innovation AB may still be in the early stages of developing a comprehensive climate strategy. As the company does not inherit emissions data from a parent organisation, it operates independently in terms of its climate impact reporting. Without specific targets or initiatives, it remains unclear how Athanase Innovation AB plans to address carbon emissions or contribute to climate action within its industry.
How Carbon Intensive is Athanase Innovation AB (publ)'s Industry?
How Carbon Intensive is Athanase Innovation AB (publ)'s Location?
Athanase Innovation AB (publ)'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Athanase Innovation AB (publ) has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
